Scholars Central

Case reportPublished 30 Mar 2022

Use of Tranexamic Acid for The Treatment of ACE Inhibitor Induced Angioedema

Authors: Ramzan Judge, Matthew Freidel, Farhan Qadeer

Journal of Clinical and Medical Case Studies

Volume 7 · Issue 3 · Pages 6–10

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Angiotensin Converting Enzyme Inhibitors (ACEI) is commonly prescribed antihypertensive agents in the United States and is generally safe and effective. However, in a small subset of the population, potentially fatal complications may arise as a result of their incidental effect of increasing bradykinin leading to angioedema. While there is no approved treatment, Tranexamic Acid (TXA) can decrease recovery time and improve outcomes by reducing the production of bradykinin. In this paper we discuss a patient case at our facility whose ACEI-Angioedema (ACEI-AE) improved after administration of TXA.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Medical Case Studies.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Medical Case Studies
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Ramzan Judge”
  • BylineArticles whose byline prints “Matthew Freidel”
  • BylineArticles whose byline prints “Farhan Qadeer”